(Q49118164)

18 February 2018

review article

1 reference

title

Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. (English)

1 reference

18 February 2018

0 references

1

1 reference

18 February 2018

author name string

Michael F Flessner

series ordinal

2

1 reference

18 February 2018

language of work or name

English

0 references

publication date

15 December 2009

1 reference

18 February 2018

Nature Reviews Clinical Oncology

published in

1 reference

18 February 2018

volume

7

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

page(s)

108-115

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1038/nrclinonc.2009.217

exact match

0 references

cites work

Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids.

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Use of nitrogen mustard in treatment of serous effusions of neoplastic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Strategies to examine new compounds for intraperitoneal use in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

On the importance of sensitivity to the dose-effect relationship in chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Pharmacologic principles of intraperitoneal chemotherapy for the treatment of ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Perspectives in the Pathogenesis and Management of Acute Renal Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

High interstitial fluid pressure - an obstacle in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Drug penetration in solid tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Let's return to the "belly bath"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Hyperthermia adds to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

31 March 2020

Pseudomyxoma peritonei

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Peritoneal carcinomatosis from colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Intraperitoneal chemotherapy for ovarian cancer: overview and perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

The antitumor effect of hyperthermia combined with fluorouracil and its analogues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.217

Is the peritoneum a significant transport barrier in peritoneal dialysis?

31 March 2020

1 reference

12 December 2020

Determinants of paclitaxel penetration and accumulation in human solid tumor

1 reference

12 December 2020

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

1 reference

12 December 2020

High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer.

1 reference

12 December 2020

Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule

1 reference

12 December 2020

cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

1 reference

12 December 2020

Theoretical and experimental bases of intraperitoneal chemotherapy.

1 reference

12 December 2020

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

1 reference

12 December 2020

Endothelial glycocalyx and the peritoneal barrier.

1 reference

12 December 2020

A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity

1 reference

12 December 2020

A distributed model of peritoneal-plasma transport: theoretical considerations.

1 reference

12 December 2020

In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.

1 reference

12 December 2020

10.1038/NRCLINONC.2009.217

Identifiers

DOI

1 reference

18 February 2018

Dimensions Publication ID

1050343581

0 references

1 reference

18 February 2018